We have located links that may give you full text access.
CLINICAL TRIAL
JOURNAL ARTICLE
Testosterone supplementation in hypogonadal men: our personal experience.
Archivio Italiano di Urologia, Andrologia 2005 December
INTRODUCTION AND OBJECTIVES: Around thirty years of age, we assist to a physiological, progressive and slow involution of the testicular function accompanied by a fall of the plasmatic levels of testosterone. Rarely hypogonadism is manifest in so young age with signs and symptoms, unless it is subsequent to severe events. After 50 years of age, it can present with a series of aspects that negatively influence the physical and sexual efficiency. The aim of this study is to prove if the replacement therapy with testosterone is able to restore a physiological gonadal function, without incurring in unpleasant side effects to prostate, liver and cardiac muscle.
MATERIAL AND METHODS: We report our experience on 123 patients over 60 years of age (mean age 71) and 12 patients over 30 (mean age 37). These last ones were submitted to andrologic assessment after genital trauma. Both groups of patients have reached our observation from December 2000 to June 2003 for important asthenia and decrease of libido associated with impairment of secondary sexual characters and erectile deficit of various degrees. Respectively 76 and 12 patients did not show contraindications for testosterone therapy and they began injections with testosterone for at least 6 months.
RESULTS AND CONCLUSIONS: Although compliance to testosterone treatment has not been equal in the time in all the subjects, undesirable effects are not highlighted. All the patients have reported complete or partial recovery of physical efficiency and improvement of sexual life, evaluated by means of IIEF scale and ADAM-AMS questionnaires. The replacement pharmacological treatment with testosterone improves the physical and sexual performance of the adult patient affected by symptomatic hypogonadism.
MATERIAL AND METHODS: We report our experience on 123 patients over 60 years of age (mean age 71) and 12 patients over 30 (mean age 37). These last ones were submitted to andrologic assessment after genital trauma. Both groups of patients have reached our observation from December 2000 to June 2003 for important asthenia and decrease of libido associated with impairment of secondary sexual characters and erectile deficit of various degrees. Respectively 76 and 12 patients did not show contraindications for testosterone therapy and they began injections with testosterone for at least 6 months.
RESULTS AND CONCLUSIONS: Although compliance to testosterone treatment has not been equal in the time in all the subjects, undesirable effects are not highlighted. All the patients have reported complete or partial recovery of physical efficiency and improvement of sexual life, evaluated by means of IIEF scale and ADAM-AMS questionnaires. The replacement pharmacological treatment with testosterone improves the physical and sexual performance of the adult patient affected by symptomatic hypogonadism.
Full text links
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app